The Chagas Clinical Research Platform gathers different stakeholders from more than 20 countries, supporting the development of new drugs to treat the infection caused by the Trypanosoma cruzi parasite. The Chagas Platform’s plenary meetings are held every two years and bring together prominent researchers and stakeholders involved with Chagas disease. During these meetings, participants discuss the current evidence and research, pondering the community’s contribution to overcome the innovation, research, and access challenges posed by Chagas.
Sessions
Reflecting on 10 years of innovation and collaboratoin: The Chagas Clinical Research Platform
Time: 8:30-9:00
Speakers:
|
Eliminating Chagas disease as a public health problem: What is the role of research?
Time: 9:00-9:20
Moderator: Sergio Sosa-Estani, Head of Chagas Clinical Programme, DNDi
Speaker:
|
Validation of rapid tests: Key questions to answer
Time: 9:20-9:50
Moderator: Andrea Marchiol, Chagsa Access Project Manager, DNDi
Speaker:
|
Back translation of animal models and clinical data into drug discovery
Time: 9:50-10:30
Moderator: Jadel Kratz, Discovery Manager, DNDi
Speakers:
|
Evaluation of antibody dynamic response to the exposure and clearance of T. cruzi infection: A clinical perspective
Time: 10:30-11:00
Moderator: Eric Chatelain, Head of Drug Discovery Programme, DNDi
Speaker:
|
Panel: Latest updates on clinical trials for Chagas disease
Time: 11:30-12:45
Moderator: Sergio Sosa-Estani, Head of Chagas Clinical Programme, DNDi
Speakers:
|
